Literature DB >> 18589867

Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice.

Peigen Huang1, Dan G Duda, Rakesh K Jain, Dai Fukumura.   

Abstract

The inbred FVB mouse strain is used extensively in cancer research. Transgenic mice with an FVB/N background in which the expression of green fluorescent protein is under the control of various promoters have been used widely for the last decade. However, little is known about the incidence and characteristics of spontaneous tumors in these mice. In addition, only a few tumor lines have been established for use in this particular mouse strain. Our aim was to initiate a database of spontaneous tumors in our retired FVB/N breeders, analyze the histopathologic characteristics of these tumors, and establish novel tumor lines in vivo and in vitro. A total of 234 (40 male, 194 female) breeder mice were observed during their natural lifespans. The incidence of spontaneous tumors was 45.0% in male mice and 52.8% in female mice. All tumors in male mice were lung alveolar-bronchiolar (AB) neoplasms, except for 1 testis interstitial cell tumor. In female mice, histopathologic examination revealed 48 lung AB tumors, 27 mammary gland tumors, 13 ovarian tumors, and 14 other tumors. Several of these spontaneous tumors have been transplanted into FVB/N mice. One mammary adenocarcinoma (MCaP0008) and 1 lung AB carcinoma (LAP0297) were successfully transplanted subcutaneously and passaged serially in vivo. Subsequently, we established cell lines from both tumors, which were maintained in monolayer in vitro. Both of the grafted tumors and cell lines are tumorigenic in VEGF(P)-GFP/FVB and Tie2(P)-GFP/FVB mice. Establishment of these novel tumor lines will benefit both in vivo and in vitro studies on the pathophysiology of cancer in this relatively new but widely used mouse strain.

Entities:  

Mesh:

Year:  2008        PMID: 18589867      PMCID: PMC2693079     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  17 in total

1.  Universal GFP reporter for the study of vascular development.

Authors:  T Motoike; S Loughna; E Perens; B L Roman; W Liao; T C Chau; C D Richardson; T Kawate; J Kuno; B M Weinstein; D Y Stainier; T N Sato
Journal:  Genesis       Date:  2000-10       Impact factor: 2.487

2.  Conventional and high-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions.

Authors:  Timothy P Padera; Brian R Stoll; Peter T So; Rakesh K Jain
Journal:  Mol Imaging       Date:  2002 Jan-Mar       Impact factor: 4.488

3.  Age distribution of cancer in mice: the incidence turnover at old age.

Authors:  F Pompei; M Polkanov; R Wilson
Journal:  Toxicol Ind Health       Date:  2001-02       Impact factor: 2.273

4.  Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.

Authors:  Dan G Duda; Kenneth S Cohen; Sergey V Kozin; Jean Y Perentes; Dai Fukumura; David T Scadden; Rakesh K Jain
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

5.  Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice.

Authors:  P Huang; A Allam; A Taghian; J Freeman; M Duffy; H D Suit
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

6.  FVB/N: an inbred mouse strain preferable for transgenic analyses.

Authors:  M Taketo; A C Schroeder; L E Mobraaten; K B Gunning; G Hanten; R R Fox; T H Roderick; C L Stewart; F Lilly; C T Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.

Authors:  M Leunig; F Yuan; M D Menger; Y Boucher; A E Goetz; K Messmer; R K Jain
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

8.  Differential transplantability of tumor-associated stromal cells.

Authors:  Dan G Duda; Dai Fukumura; Lance L Munn; Michael F Booth; Edward B Brown; Peigen Huang; Brian Seed; Rakesh K Jain
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

9.  Persistent mammary hyperplasia in FVB/N mice.

Authors:  Ana I Nieto; G Shyamala; Jose J Galvez; Gudmundur Thordarson; Lalage M Wakefield; Robert D Cardiff
Journal:  Comp Med       Date:  2003-08       Impact factor: 0.982

10.  Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling.

Authors:  Lalage M Wakefield; Gudmundur Thordarson; Ana I Nieto; G Shyamala; Jose J Galvez; Miriam R Anver; Robert D Cardiff
Journal:  Comp Med       Date:  2003-08       Impact factor: 0.982

View more
  22 in total

1.  Malignant cells facilitate lung metastasis by bringing their own soil.

Authors:  Dan G Duda; Annique M M J Duyverman; Mitsutomo Kohno; Matija Snuderl; Ernst J A Steller; Dai Fukumura; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.

Authors:  Wende Li; Yujiao Liu; Weining Yang; Xiaoxing Han; Sen Li; Hao Liu; Leo E Gerweck; Dai Fukumura; Jay S Loeffler; Burton B Yang; Rakesh K Jain; Peigen Huang
Journal:  J Neurooncol       Date:  2017-10-28       Impact factor: 4.130

3.  Spontaneous nonthymic tumors in SCID mice.

Authors:  Peigen Huang; Susan V Westmoreland; Rakesh K Jain; Dai Fukumura
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

4.  Direct evidence for lineage-dependent effects of bone marrow stromal cells on tumor progression.

Authors:  Michelle R Dawson; Sung-Suk Chae; Rakesh K Jain; Dan G Duda
Journal:  Am J Cancer Res       Date:  2011       Impact factor: 6.166

5.  Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

Authors:  Woo-Young Kim; Mi-Jung Kim; Hojin Moon; Ping Yuan; Jin-Soo Kim; Jong-Kyu Woo; Guangcheng Zhang; Young-Ah Suh; Lei Feng; Carmen Behrens; Carolyn S Van Pelt; Hyunseok Kang; J Jack Lee; Waun-Ki Hong; Ignacio I Wistuba; Ho-Young Lee
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

6.  MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma.

Authors:  Yue Jiang; Ruli Gao; Chunxia Cao; Lauren Forbes; Jianping Li; Shelby Freeberg; Kristianna M Fredenburg; Jeb M Justice; Natalie L Silver; Lizi Wu; Sushama Varma; Robert West; Jonathan D Licht; Maria Zajac-Kaye; Alex Kentsis; Frederic J Kaye
Journal:  Oral Oncol       Date:  2019-10-10       Impact factor: 5.337

7.  N-nitroso-tris-chloroethylurea induces premalignant squamous dysplasia in mice.

Authors:  Tyler M Hudish; Laura I Opincariu; Anthony B Mozer; Micah S Johnson; Timothy G Cleaver; Stephen P Malkoski; Daniel T Merrick; Robert L Keith
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-15

8.  Increased vessel perfusion predicts the efficacy of immune checkpoint blockade.

Authors:  Xichen Zheng; Zhaoxu Fang; Xiaomei Liu; Shengming Deng; Pei Zhou; Xuexiang Wang; Chenglin Zhang; Rongping Yin; Haitian Hu; Xiaolan Chen; Yijie Han; Yun Zhao; Steven H Lin; Songbing Qin; Xiaohua Wang; Betty Ys Kim; Penghui Zhou; Wen Jiang; Qingyu Wu; Yuhui Huang
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

9.  Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.

Authors:  Henok Eyob; Huseyin Atakan Ekiz; Yoko S Derose; Susan E Waltz; Matthew A Williams; Alana L Welm
Journal:  Cancer Discov       Date:  2013-04-23       Impact factor: 39.397

10.  Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy.

Authors:  Yuhui Huang; Jianping Yuan; Elda Righi; Walid S Kamoun; Marek Ancukiewicz; Jean Nezivar; Michael Santosuosso; John D Martin; Margaret R Martin; Fabrizio Vianello; Pierre Leblanc; Lance L Munn; Peigen Huang; Dan G Duda; Dai Fukumura; Rakesh K Jain; Mark C Poznansky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.